Title

Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

Publication/Presentation Date

6-29-2019

Abstract

Direct oral anticoagulants (DOACs)-dabigatran, rivaroxaban, apixaban and edoxaban-are changing the landscape of clinical practice for patients requiring short and long-term anticoagulation. We report a patient with no history of kidney disease developing acute interstitial nephritis (AIN) after starting a DOAC, apixaban. To date, this is the first biopsy proven case of apixaban-induced AIN.

Volume

12

Issue

6

ISSN

1757-790X

Comments

Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

PMID: 31624064

Disciplines

Internal Medicine

PubMedID

31256051

Department(s)

Department of Medicine, Department of Medicine Faculty

Document Type

Article

Share

COinS